NYSE:DD

DuPont de Nemours Inc. (DD)

134.89
+0.72 (0.54%)
as of Jul 15, 2026, 7:59:58 pm Market Open.
50 watching
0
Investor Insights
star iconJul 15, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

DuPont de Nemours Inc. is scheduled to report on Tuesday, and opinions regarding its future are mixed yet insightful. One expert mentions a recent parabolic move in the stock, suggesting cautiousness, while another praises the CEO's leadership in their successful sectors, such as water and materials. A significant consideration is the company's upcoming split into two separate entities, which could potentially unlock value, with predictions indicating a possible worth of $100 per share afterward. Experts agree that the individual components of the business are likely to perform better than the company as a whole, making this an enticing break-up narrative. Therefore, patience may be required as investors await the developments from the upcoming earnings report.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
Bristol-Myers, BMY
BUY

Chart shows a little bit of a classic trend channel which is moving up. Probably at a reasonably good point as it is touching the bottom of the trend channel. There is some overhead resistance in the low $50’s, which could be your 1st target.

PAST TOP PICK

(A Top Pick Nov 2/11. Up 7.12%.)

BUY ON WEAKNESS

One of his favourite companies but he is waiting for it to pull back a bit. Most recently spun off the auto paint division, which is a plus. Major focus in recent years has been on agriculture. He would prefer it closer to the mid-$40’s. Has always liked their innovation and technological expertise.

BUY

They aren’t the old stodgy chemical company any more. They are really a science and technology company. About 20%-25% of their business comes through the agricultural side. Well managed. Well priced. Pays a decent dividend.

BUY ON WEAKNESS

His base case scenario is for a recession sometime next year and this is a cyclical story. A very well run and innovative company. There has been very modest growth globally and he doesn’t see this improving for at least a year and at some point it seems reasonable the markets will anticipate that and potentially sell these things off. This is one he would buy on weakness, which he thinks will happen in the 1st quarter.

BUY ON WEAKNESS

There are many facets to their business. He would prefer to see a little bit of weakness in the share price before allocating new capital to it. They’ll be in better stead once growth returns to the global economy simply by the nature of their businesses.

WEAK BUY

(Market Call Minute) Around its model price

BUY
Would lower oil prices help this company? Oil is one of the input costs in their chemical division but that is only one of many of their divisions. Growth in this company is coming from their agriculture products. 11X next year’s earnings. Good yield. Very attractive entry point.
TOP PICK
Very innovative company. 30% of last year's revenues came from products that didn’t exist 4 years ago. Trades at about 12X this year's earnings, 11X next year's and has a 3% yield. Likes the agricultural area.
TOP PICK
In many different fields. They are really a science and technology company. Development of seeds and herbicides. Doing very, very well. Double-digit growth potential in revenue and earnings. Good fundamentals and low valuation.
BUY
(Market Call Minute.) Good play on increasing industrial manufacturing in the US.
HOLD
Has become a high tech chemical company, 25% of business in agricultural business, rest in traditional chemicals. 60% of business in overseas. Trading at 11-12X earnings. Has decent dividend.
TOP PICK
24% of revenue and 31% of EBITDA last year was from the agricultural side. Yield of 3%. 7% free cash flow yield. Still room for them to increase the yield.
PAST TOP PICK
(A Top Pick Aug 19/10. Up 2.65%.) Extremely commodity sensitive. This is a Buy in here.
PAST TOP PICK
(A Top Pick Aug 19/10. Up 20.48%.)
Showing 61 to 75 of 124 entries